| VERMA, Subodh, Nitish K DHINGRA, Javed BUTLER, Stefan D ANKER, Joao Pedro FERREIRA, Gerasimos FILIPPATOS, James L JANUZZI, Carolyn S P LAM, Naveed SATTAR, Barbara PEIL, Matias NORDABY, Martina BRUECKMANN, Stuart J POCOCK, Faiez ZANNAD and Milton PACKER. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial. LANCET DIABETES & ENDOCRINOLOGY. 2022, vol. 10, No 1, p. 35-45. ISSN 2213-8587. Available from: https://dx.doi.org/10.1016/S2213-8587(21)00292-8. |
Other formats:
BibTeX
LaTeX
RIS
@article{2265037,
author = {Verma, Subodh and Dhingra, Nitish K and Butler, Javed and Anker, Stefan D and Ferreira, Joao Pedro and Filippatos, Gerasimos and Januzzi, James L and Lam, Carolyn S P and Sattar, Naveed and Peil, Barbara and Nordaby, Matias and Brueckmann, Martina and Pocock, Stuart J and Zannad, Faiez and Packer, Milton and Ludka, Ondřej},
article_number = {1},
doi = {http://dx.doi.org/10.1016/S2213-8587(21)00292-8},
issn = {2213-8587},
journal = {LANCET DIABETES & ENDOCRINOLOGY},
title = {Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial},
volume = {10},
year = {2022}
}
TY - JOUR
ID - 2265037
AU - Verma, Subodh - Dhingra, Nitish K - Butler, Javed - Anker, Stefan D - Ferreira, Joao Pedro - Filippatos, Gerasimos - Januzzi, James L - Lam, Carolyn S P - Sattar, Naveed - Peil, Barbara - Nordaby, Matias - Brueckmann, Martina - Pocock, Stuart J - Zannad, Faiez - Packer, Milton - Ludka, Ondřej
PY - 2022
TI - Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial
JF - LANCET DIABETES & ENDOCRINOLOGY
VL - 10
IS - 1
SP - 35-45
EP - 35-45
SN - 22138587
ER -
VERMA, Subodh, Nitish K DHINGRA, Javed BUTLER, Stefan D ANKER, Joao Pedro FERREIRA, Gerasimos FILIPPATOS, James L JANUZZI, Carolyn S P LAM, Naveed SATTAR, Barbara PEIL, Matias NORDABY, Martina BRUECKMANN, Stuart J POCOCK, Faiez ZANNAD and Milton PACKER. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial. \textit{LANCET DIABETES \&{}amp; ENDOCRINOLOGY}. 2022, vol.~10, No~1, p.~35-45. ISSN~2213-8587. Available from: https://dx.doi.org/10.1016/S2213-8587(21)00292-8.
|
